The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses (Rota-biome)
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
A NA clinical study on Intestinal Bacteria Flora Disturbance and Reaction - Vaccine Nos, this trial is completed. The trial is conducted by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) and has accumulated 8 data snapshots since 2015. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jul 2018 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — Jul 2018 [monthly]
Completed NA
▶ Show 3 earlier versions
-
Aug 2017 — Jun 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Feb 2017 — Aug 2017 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Sep 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Centers for Disease Control and Prevention
- Wageningen University and Research
For direct contact, visit the study record on ClinicalTrials.gov .